InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: EichKing post# 8041

Wednesday, 11/08/2017 2:24:51 PM

Wednesday, November 08, 2017 2:24:51 PM

Post# of 44784
Hey EichKing I share in your pessimistic views of this company. Not all roses by any means. But a contract either for funding or stockpiling for ARS is a distinct possibility. Don't think it will happen this year, but hoping for an early Christmas present on that one.

If we don't get something started on ARS pivotal trial this year or first quarter latest next year, dilution will come again soon after. Obviously a partnership or something else would change that as well.

The grant covers a significant portion of the CLI trial, but not all. And with Pluristem directly only receiving $3.4 million directly, doesn't keep us afloat much longer. And I can't, based on previous trials etc., see this trial moving quickly.

I believe so much of the future of this company, or stock price and future dilution concerns at least, rests entirely on ARS. I am astonished it has taken this long already. But if the U.S. wants it, budget or no budget they will get it.